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ABSTRACT Mice lacking the a-subunit of the heterotri-
meric guanine nucleotide binding protein Gq (Gaq) are viable
but suffer from ataxia with typical signs of motor discoordi-
nation. The anatomy of the cerebellum is not overtly disturbed,
and excitatory synaptic transmission from parallel fibers to
cerebellar Purkinje cells (PCs) and from climbing fibers
(CFs) to PCs is functional. However, about 40% of adult Gaq
mutant PCs remain multiply innervated by CFs because of a
defect in regression of supernumerary CFs in the third
postnatal week. Evidence is provided suggesting that Gaq is
part of a signaling pathway that is involved in the elimination
of multiple CF innervation during this period.
In a variety of signaling systems, many of the components of
the G protein family are highly homologous in structure and
activity (1). Thus, for example, there are two similar members
of the heterotrimeric Gq family, Gaq and Ga11, that are
responsible for coupling receptors to the pertussis toxin-
insensitive activation of isoforms of phospholipase C-b (PLC-
b) (for review see ref. 2). They share 88% amino acid sequence
identity and are expressed together in almost every cell type (3,
4). The receptors activating Gq family members in mammalian
systems do not discriminate between Gaq and Ga11 (5–7).
Similarly, there appears to be little difference between the
abilities of both G protein a-subunits to regulate phospho-
lipase C b isoforms. Thus, Gaq and Ga11 indistinguishably
activate the b1, b3, and b4 isoforms of PLC, and both are
equally poor regulators of PLC- b2 (6, 8–11). These observa-
tions raise fundamental questions about the function of G
protein-mediated signaling pathways in the nervous system.
Are different isoforms of receptors, G proteins, and effectors
used to generate specific signaling pathways in different cells?
If they are, they could account for cell-type-specific kinetic and
regulatory properties. Do several isoform pathways coexist in
the same cell? If so, are their functions redundant and over-
lapping or do they participate in separable physiological
activities? What prevents or maintains cross-talk between
these systems?
A clearer picture of the specificity of these pathways requires
genetic approaches combined with morphological and physi-
ological analyses, because biochemical reconstitution may
eliminate organizational elements, developmental staging, or
additional components in the signaling pathway that are
necessary for specificity. To explore the biological significance
of the diversity among Gaq family members, we inactivated the
gene encoding the Gq a-subunit (Gnaq) in mouse embryonic
stem cells and generated mice deficient in Gaq. Although both
Gaq and Ga11 are found in most cells, the relative levels of
expression vary among different tissues. In most regions of the
rat central nervous system, Gaq expression levels exceed those
of Ga11 by 2- to 5-fold (12). Expression of Gaqy11 in the rat
central nervous system is highest in the dendrites of cerebellar
Purkinje cells (PCs) and hippocampal CA1 pyramidal cells
(13). Both areas are very rich in glutamatergic synapses and
show high expression levels of metabotropic glutamate recep-
tors type 1 (mGluR1) and 5 (mGluR5), respectively (14–16).
Both mGluRs are known to couple to Gaq and Ga11 and have
been implicated in functions required for the modulation of
neuronal activity (for review see refs. 17 and 18). The mGluR1
has been shown to be required for postnatal elimination of
multiple climbing fiber (CF) innervation of PCs (19). In the
cerebellum of newborn rats and mice, each PC is innervated by
multiple CFs. Massive elimination of supernumerary CF-PC
synapses occurs during the first 3 postnatal weeks, and a state
is reached at about postnatal day 20 (P20), in which most PCs
are innervated by single CFs. This developmental change
appears to depend on the presence of intact granule cells and
of functioning synapses between PFs and PCs (20). Failure of
CF-PC synapse elimination results in persistent multiple climb-
ing fiber innervation, which correlates with impaired motor
coordination (19, 21). Thus, Gaq deficiency might be expected
to affect cerebellar development, and our results support this
prediction.
MATERIALS AND METHODS
Generation of Gaq Mutant Mice. A genomic Gaq clone was
isolated from a 129ySv mouse genomic l phage library (Strat-
agene) with a probe derived from the Gaq cDNA. The genomic
clone used for gene targeting contained the two last exons of
the Gaq gene. To generate a null mutation, a 2.3-kb BglII
fragment containing an exon coding for amino acids 246–297
of Gaq was replaced by the neo gene from plasmid pMC1neo
PolyA (Stratagene). The targeting vector contained 5.5 kb of
upstream sequence as the 59 arm and 2.6 kb of intron sequence
as the 39 arm. Cells of the 129ySv mouse embryonic stem cell
line CJ7 were transfected with 20 mg linearized targeting
vector by electroporation (Bio-Rad Gene Pulser set at 240 V
and 500 mF). G418 selection (150 mgyml geneticin; GIBCOy
BRL) was added 24 h after transfection, and selected cell
clones were isolated after 1 week of selection. Correctly
targeted embryonic stem (ES) cell clones were identified by
PCR using primers hybridizing to the Neo cassette and to the
intron sequence just outside the 39 arm of the targeting
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construct. Positive clones were confirmed by Southern blot
analysis of ES cell DNA. DNA was digested with AflII and
probed with a 1.3-kb DNA fragment from the 39 f lanking
region (Fig. 1 A and B). Chimeric mice were generated using
three independently targeted ES cell clones by aggregation of
ES cells with CD1 morulae (22) or by injection of ES cells into
C57yBL blastocysts (23). Chimeras were bred with C57yBL
and 129ySv mice to generate hemizygous animals. The outbred
mice (C57yBL) were more robust and showed higher fertility
than the inbred (129ySV) mice. We used the outbred mice for
most of the experiments. However, all of our results were
repeated in the inbred animals, and no significant differences
were found. Germ-line transmission was confirmed by PCR
and Southern blot analysis.
Rotorod and Runway Test. The rotorod apparatus is a plastic
cylindrical rod 3 cm in diameter and 13 cm long. The rod is
supported at the ends by two walls and is 25 cm from the base
of the walls. The walls at the ends of the rod are high enough
so that the mice cannot climb off the rod. For each trial on the
stationary rod test or the rotorod test, the mice are placed on
the rod and timed until they fell off the rod. They were timed
up to a maximum of 1 min. The intertrial interval was 10 min.
For the rotorod test, the rod was turned by an electric motor
at 10 rpm.
Immunohistology. Under deep anesthesia with chloral hy-
drate (350 mgykg body weight, intraperitoneally), mice at the
second and fifth postnatal months were perfused transcardially
with 4% paraformaldehyde in 0.1 M sodium phosphate buffer
(pH 7.2). The brains were excised quickly from the skull and
immersed overnight in the same fixative. After sectioning at 50
mm in thickness by a microslicer (Dosaka) in the parasagittal
plane, the sections were used for Nissl staining with toluidine
blue and for immunostaining with rabbit anti-rat spot 35y
calbindin antibody (1:1,000) (24), and sections were incubated
for 2 h with FITC-labeled goat anti-rabbit IgG (1:100, Jackson
ImmunoResearch) and observed by a MRC1024 confocal
laser-scanning microscope (Bio-Rad). Paraffin sections (4 mm
in thickness) were prepared for Nissl staining with toluidine
blue and immunostaining with rabbit anti-GaqyGa11 (341–359
aa residues) antibody (0.2 mgyml, Santa Cruz Biotechnology),
prediluted rabbit anti-glial fibrillary acidic protein (GFAP)
antibody (DAKO), and guinea pig anti-mGluR1 antibody.
Immunoreacted sections were then incubated with biotin-
ylated secondary antibody and ABC complex and observed
with a bright-field light microscope (AX 80, Olympus).
Antibodies. Rabbit polyclonal anti-GaqyGa11, anti-PLC-b3,
and anti-PLC-b3 antibodies were from Santa Cruz Biotech-
nology, and anti-mGluR1 antibodies used for Western blot
analysis were from Chemicon. Rabbit antisera specific for Gaq,
Ga11, Gao, and Ga13 were raised against specific peptides.
Electrophysiology. Sagittal cerebellar slices of 200- to
300-mm thickness were prepared from the wild-type and
mutant mice as described previously (25–28). Whole cell
recordings were made from visually identified PCs using a 403
water immersion objective attached to either a Olympus
(BH-2) or Zeiss (Axioskop) upright microscope (25, 26).
Resistance of patch pipettes was 3–6 MV when filled with an
intracellular solution composed of 60 nM CsCl, 30 nM Cs
D-gluconate, 20 nM TEA-Cl, 20 nM BAPTA, 4 nM MgCl2, 4
nM ATP, and 30 nM Hepes (pH 7.3, adjusted with CsOH). The
composition of standard bathing solution was 125 mM NaCl,
2.5 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 1.25 mM NaH2PO4,
26 mM NaHCO3, and 20 mM glucose, which was bubbled
continuously with a mixture of 95% O2 and 5% CO2. Bicu-
culline (10 mM) was always present in the saline to block
spontaneous inhibitory postsynaptic currents (27, 29). Ionic
currents were recorded with either Axopatch-1D (Axon In-
struments) or EPC-9 patch-clamp amplifier (HEKA Electron-
ics, LambrechtyPfalz, Germany) and stored on a DAT data
recorder (PC204, Sony, Tokyo) for later analysis. Stimulation
and on-line data acquisition were performed using the PULSE
program on a Macintosh computer (version 7.5, HEKA). The
signals were filtered at 3 kHz and digitized at 20 kHz. Fitting
of the decay phases of excitatory postsynaptic currents (EP-
SCs) was done with the PULSE-FIT program (version 7.5,
HEKA). For stimulation of CFs and PFs, a glass pipette with
5- to 10-mm tip diameter filled with standard saline was used.
Square pulses (duration, 0.1 ms; amplitude, 0–100 V for CF
stimulation, 1–10 V for PF stimulation) were applied for focal
stimulation.
RESULTS
Generation and Characterization of Gaq-Deficient Mice. To
disrupt the Gaq gene locus, we constructed a targeting vector
containing a 10.4-kb Gaq genomic DNA fragment disrupted by
a neomycin phosphotransferase gene (Fig. 1 A). Three inde-
pendently targeted embryonic stem cell clones generated by
homologous recombination transmitted the targeted mutation
FIG. 1. Targeted disruption of the murine Gaq gene. (A) Part of
the wild-type Gaq locus containing the two last exons (wt allele), the
targeting construct, and the targeted locus (mut. allele) are shown.
Neo, neomycin resistance gene. The sizes of the AflII fragments
predicted to hybridize to the indicated diagnostic probe are shown.
Restriction endonucleases: A, AflII; B, BglII; N, NdeI; S, SacI; Sm,
SmaI; and X, XhoI. (B) Southern blot analysis of AflII-digested
genomic DNA from wild-type (1y1), hemizygous (2y1), and ho-
mozygous mutant mice (2y2) with the diagnostic probe indicated in
A. (C) Western blot analysis of whole brain cholate extracts from
wild-type (1y1) and homozygous Gaq mutant mice (2y2) with
antibodies recognizing the a-subunits of Gq (Gaq), G11 (Ga11), G13
(Ga13), and Go (Gao). (D) Western blot analysis of cerebellar
membrane fractions from wild-type (1y1) and homozygous Gaq
mutant animals (2y2) with antibodies recognizing the a-subunits of
Gq and G11 (GaqyGa11), Go (Gao), type 1 metabotropic glutamate
receptor (mGluR1), phospholipase C-b3 (PLC-b3), and phospho-
lipase C-b4 (PLC-b4).
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of the Gaq gene through the germ line (Fig. 1B). Western blot
analysis of cholate extracts from whole brain membranes (Fig.
1C) and of cerebellar membrane proteins (Fig. 1D) demon-
strated that the homozygous mutant mice (2y2) had no
detectable Gaq protein, whereas the content of Ga11, Ga13,
and Gao appeared to be unaffected by the Gaq mutation.
Similarly, the amounts of mGluR1 metabotropic glutamate
receptors and of the b3 isoform of phospholipase C (PLC-b3)
in cerebellar membrane fractions were not appreciably af-
fected by the Gaq mutation, whereas the content of the b4
isoform of phospholipase C (PLC-b4) was increased about
2-fold in cerebella from mutant mice when compared with
wild-type animals (Fig. 1D).
Mice heterozygous for the targeted mutation of the Gaq
gene appeared normal and showed no obvious defects over a
20-month period. In contrast, homozygous mutant mice
showed increased mortality during the first postnatal day. The
mice have a defect in platelet aggregation that is a result of the
absence of Gaq (30), and the mortality appears to result from
internal bleeding that occurs during birth trauma. Sixty to 70%
of homozygous mutant newborns survived the postnatal pe-
riod and developed clear signs of motor coordination deficit,
which became obvious about 3 weeks after birth. The animals
displayed awkward and jerky movements and loss of balance
during rearing, and occasionally fell on their side. Homozygous
mutant mice had difficulties balancing on the stationary
rotorod. When placed on a turning rotorod, the homozygous
mutant mice immediately fell off and their performance did
not improve with increasing trial numbers. In contrast, het-
erozygous and wild-type mice managed to stay for some time
on the turning rod, and duration of their stay increased with
increasing trial numbers (Fig. 2).
Gaq mutant mice showed an ataxic gait with typical wob-
bling and tottering steps, which became more severe when the
mice increased their walking speed. Mutant mice cannot walk
in a straight line and tend to drag their feet along the floor
(data not shown). Motor coordination deficits and ataxia have
been described in a variety of mice with mutations affecting the
morphology or function of the cerebellar cortex. No obvious
morphological defects could be observed on examination of
the peripheral and central nervous system of Gaq homozygous
mutant mice. Extensive morphological examination of the
cerebellar cortex by histological, immunohistochemical, and
electron microscopic techniques indicated that deletion of the
Gaq gene did not affect gross development of the cerebellar
anatomy, cell production, cytodifferentiation, and formation
of PF-PC synapses (data not shown).
By using affinity-purified antibodies against GaqyGa11, the
cerebella of wild-type and Gaq mutant mice at P7, P14, and
P21 were immunohistochemically examined to reveal the
localization of GaqyGa11 in the cerebellar cortex. At all of the
stages examined, the antibody stained the molecular layer
intensely and the granular layer weakly in the wild-type
cerebellum (Fig. 3 A–C). At P7, low to moderate levels of the
GaqyGa11 immunoreactivity were detected in the thin molec-
ular layer between PC somata and the external granular layer.
The level gradually increased from P7 to P21, when the
immunoreactivity was observed as tiny puncta occupying the
molecular layer at high density (Fig. 3C). The immunoreac-
tivity was markedly reduced at each corresponding age (Fig. 3
D–F) in the mutant. However, low levels of residual staining
were detected in the molecular layer, representing the Ga11
immunoreactivity. The residual immunoreactivity showed a
distribution pattern similar to the wild-type cerebellum. There-
fore, it is likely that Gaq and Ga11 are both localized in the
molecular layer, with the dominant presence of the Gaq
subtype.
Gaq Mutant Purkinje Cells Are Multiply Innervated by
Climbing Fibers. In sagittal cerebellar slices prepared from 22-
to 57-day-old (P22–P57) wild-type mice or age-matched Gaq
mutant animals, CFs were stimulated in the granule cell layer,
and evoked responses in single PCs were recorded using
patch-clamp techniques in the whole cell configuration (26, 27,
29). As the stimulus intensity was gradually increased (pulse
width, 0.1 ms, strength 0–100 V), a large EPSC was elicited in
an all-or-none fashion in the majority of wild-type PCs (Fig.
FIG. 2. Rotorod test. Each point shows the mean 6 SEM of the
times each group stayed on the rod from each trail. n 5 10 for Gaq
(1y1) and Gaq (2y1); n 5 12 for Gaq (2y2).
FIG. 3. Immunohistochemistry for GaqyGa11 in the cerebellum of
wild-type (A–C) and Gaq mutant mice (D–F). A and D, P7; B and E,
P14; C and F, P21. EG, external granular layer; Pc, Purkinje cell layer.
A–F were taken at the same magnification. [Bars 5 50 mm (F).]
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4Aa). In other wild-type PCs, CF-EPSCs showed two or three
discrete steps (Fig. 4Ab). The number of discrete steps of
CF-EPSCs represents the number of CFs innervating the
recorded PC (19–21). Thus, as summarized in the frequency
distribution histogram (Fig. 4B Left), 82.6, 14.8, and 2.6% of
wild-type PCs recorded in the present study (P22–P57) are
innervated by one, two, and three CFs, respectively. On the
other hand, in Gaq mutant PCs, 59.6% had single CF-EPSC
steps (Fig. 4Ac), whereas 28.2 and 12.1% had two and three
discrete steps, respectively (Fig. 4Ad). The frequency distri-
bution histogram (Fig. 5B Left) shows significant differences
between wild-type and mutant mice (P , 0.001, x2 test).
Similar experiments have been done with three Gaq heterozy-
gotes (P53–P55), in which 88.7, 9.4, and 1.9% of PCs were
innervated by one, two, and three CFs, respectively. These
values were indistinguishable from those of wild-type mice
(P . 0.05, x2 test).
The difference of CF innervation between the wild-type and
Gaq mutant mice during P22–P57 could be a result of the
retardation of general cerebellar maturation in the Gaq mu-
tant mice. To assess this possibility, we examined CF-EPSCs in
older mice (P72–P109) (Fig. 4B Right). The differences be-
tween the frequency distributions of PCs during P22–P59 and
those during P70–P109 were not significant for either the
wild-type or the mutant mice (P . 0.05, x2 test). Thus,
retardation of general maturation is not likely to be the case.
Climbing Fiber Innervation During Early Postnatal Days.
To examine the state in early postnatal development when the
abnormality becomes obvious in the Gaq mutant, we followed
the developmental course of CF innervation. We observed
that during the first postnatal week (P1–P7), the majority of
PCs were multiply innervated by CFs in both wild-type and
mutant mice (Fig. 5A). However, the frequency distribution of
the number of CF-EPSC steps per PC in the mutant mice was
not significantly different from that in the wild-type mice (P .
0.05, x2 test). During the second postnatal week (P8–P14), the
percentage of PCs with multiple CF-EPSC steps decreased
markedly in both wild-type and mutant mice (Fig. 5B). The
distributions were not significantly different between the two
strains (P . 0.05, x2 test). In contrast, the frequency distri-
butions between the two strains during the third postnatal
week (P15–P21) were markedly different (P , 0.01, x2 test).
This indicates that a higher percentage of the PCs were
multiply innervated by CFs in the Gaq mutant than in the
wild-type mice. These results suggest that regression of mul-
tiple CF innervation initially occurs normally, but the process
is specifically impaired during the third postnatal week in the
Gq mutant mice.
Other Electrophysiological Parameters of Gaq Mutant EP-
SCs Are Normal. The kinetics of CF-EPSCs were normal in the
FIG. 4. Multiple climbing fiber innervation of Purkinje cells in
mature Gaq mutant mice. (A) EPSCs elicited by stimulation of
climbing fibers (CFs) in the granule cell layer in wild-type (a, b) and
Gaq mutant (c, d) Purkinje cells (PCs). Records in a, b, c, and d were
taken from mice at postnatal day 50 (P50), P80, P46, and P46,
respectively. One or two traces are superimposed at each threshold
intensity. Stimuli were applied at 0.2 Hz. Holding potentials were 210
mV for a, b, and c and 0 mV for d. (B) Summary histograms showing
number of discrete steps of CF-EPSCs of the wild-type (open columns)
and mutant (hatched columns) PCs. Data obtained from mice at
P22–P57 (a) and at P72–P109 (b), respectively. Numbers of tested PCs
at P22–P57 (a) are: n 5 115 (from seven wild-type mice) and n 5 124
(from eight Gaq mutant mice). Those at P60–P109 (b) are: n 5 72
(from four wild-type mice) and n 5 42 (from three mice). All cells were
studied blind to the mouse genotype.
FIG. 5. Early postnatal development of CF innervation. (A Left)
CF-EPSCs of the wild type (P7, holding potential, 230 mV) and Gaq
mutant (P6, holding potential, 260 mV) PCs. One or two traces were
superimposed at each threshold intensity. Stimuli were applied at 0.2
Hz. (A Right) Summary graph showing numbers of discrete steps of
CF-EPSCs of the wild type (open columns) and mutant (hatched
columns) PCs from mice at P1–P7. Numbers of tested PCs are n 5 60
(from four wild-type mice, 45 cells studied blind to the mouse
genotype) and n 5 61 (from five Gaq mutant mice, 46 cells studied
blind). (B) Similar to A, but with examples of CF-EPSCs of the wild
type (P10, holding potential, 220 mV) and Gaq mutant (P10, holding
potential, 220 mV) PCs and summary graph of the data from mice at
P8–P14. Numbers of tested PCs are n 5 97 (from six wild-type mice)
and n 5 58 (from four Gaq mutant mice). All cells were studied blind
to the mouse genotype. (C) Similar to A and B, but with examples of
CF-EPSCs of the wild type (P21, holding potential, 210 mV) and
mutant (P18, holding potential, 210 mV) PCs and summary graph of
the data from mice at P15–P21. Numbers of tested PCs are n 5 105
(from six wild-type mice) and n 5 62 (from four Gaq mutant mice).
All cells were studied blind to the mouse genotype.
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Gaq mutant mice. There is no significant difference in either
the 10–90% rise time or the decay time constant between the
Gaq mutant and wild-type mice. Short-term synaptic plasticity
examined by applying paired stimuli was normal. CF-EPSCs
showed prominent paired-pulse depression in both mono-
innervated and poly-innervated PCs derived from the Gaq
mutant and wild-type mice. The magnitudes of paired-pulse
depression were not significantly different between the wild-
type and Gaq mutant mice at varying interpulse intervals. We
also verified that the current–voltage relations of EPSCs were
linear in the mono-innervated and double-innervated PCs
from the wild-type and Gaq mutant. Furthermore, CF-EPSCs
in both wild-type and Gaq mutant mice were not affected by
an NMDA receptor blocker, DL-2-amino-5-phosphonopen-
tanoate (AP5, 100 mM), but were totally suppressed by an
AMPA receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-
dion (CNQX, 10 mM). These results indicate that the CF-
EPSCs of mature PCs from wild-type and Gaq mutant mice are
exclusively mediated by the non-NMDA subtype of glutamate
receptors.
The nature of EPSCs elicited by stimulation of PFs, the
other major excitatory input to PCs, was examined in mice at
P50–P54. There was no significant difference between the
wild-type and Gaq mutant mice in the kinetics of PF-EPSCs.
Furthermore, in both wild-type and Gaq mutant PCs, PF-
EPSCs were affected little by AP5 (100 mM) but were totally
suppressed by CNQX (10 mM). Taken together, the results
suggest that basic properties of PF-PC excitatory synaptic
transmission are largely normal in the Gaq mutant mice.
DISCUSSION
Impaired Regression of Multiple CFs in Gaq-Deficient
Mice. Our results demonstrate that the absence of Gaq results
in motor discoordination, which is a result, at least in part, of
cerebellar dysfunction. Deletion of the Gaq gene did not affect
gross development of the cerebellar anatomy, cell production,
cytodifferentiation, and formation of PF-PC synapses. Basic
electrophysiological parameters, pharmacology, and paired-
pulse responses of both CF- and PF-mediated excitatory
transmission of PCs were largely normal in Gaq mutant mice.
The most significant finding is that multiple CF innervation
persists to a substantial degree in adult Gaq mutant mice.
Regression of multiple CF innervation has been shown to
occur in at least two distinct stages both in the rat (31) and in
the mouse (21, 32). Our data show that regression of multiple
CF innervation during the second stage, which corresponds
approximately to P10–P20 (Fig. 5), appears to be specifically
impaired in Gaq mutant mice. This indicates that Gaq is
involved in the second phase of the CF synapse elimination
process. The second phase occurs at the same time as the
increased expression of Gaq in the cerebellar cortex (Fig. 3),
which also corresponds to the time of the formation of PF-PC
synapses. It is interesting that the heterozygous animals do not
show defects in CF synapse elimination or motor coordination
even though their Gaq levels are reduced. Thus, the effect is
not strictly proportional to Gaq concentration. Our data do not
bear directly on the mechanism of synapse elimination, but
they argue that the assembly of a specific signal processing
pathway incorporating Gaq is required for this function.
The Gaq mutant mice resemble the recently described PKCg
and mGluR1 mutant mice (19, 21) in that the regression of
multiple CF innervation is impaired with no gross defects in
the PF-PC synapses (19, 21). It is particularly significant that
regression of multiple CF innervation occurs normally during
the first 2 postnatal weeks in these three strains of mutant mice
and that the deficiency becomes evident during the third
postnatal week. This pattern is also consistent with the ex-
pression of PKCg in the cerebellum (33). Thus, it is likely that
both mGluR1 and Gaq mutant mice have defects in signal
transduction cascades that lead to activation of PKCg in PCs
during the third postnatal week (see below).
Role of Gaq in Elimination of Multiple Climbing Fiber
Innervation. It has been shown that most cells express Gaq
together with its close structural and functional homologue
Ga11 (3). Our in situ hybridization results indicate that cere-
bellar PCs express both Gaq and Ga11 (data not shown). Both
Western blot analysis of cerebellar membranes (Fig. 1D) and
immunohistochemistry of wild-type and Gaq-deficient cere-
bellum (Fig. 3) indicate that although the levels of Gaq found
in the cerebellar cortex exceeded those of Ga11, both proteins
are present in PCs. We conclude that the remaining Ga11 is not
able to compensate for the lack of Gaq. This conclusion is
further supported by the finding that Ga11-deficient animals
do not show any signs of motor discoordination (Tom Wilkie,
personal communication) and none of the other G protein-
deficient mice thus far generated, including Gao-deficient (34)
and Gai2-deficient (35) animals, show ataxia. It is possible that
Gaq and Ga11 have different subcellular localizations within
cerebellar PCs and that localization restricts the interaction of
mGluR1 with Gaq.
Gaq is known to couple activated receptors to the regulation
of b isoforms of PLC. Activated PLC generates two intracel-
lular messengers: inositol 1,4,5 trisphosphate (IP3) and diacyl-
glycerol (DAG). IP3 releases Ca21 from intracellular stores,
whereas DAG activates PKC, in some cases together with
Ca21. We recently have found that mice lacking the b4 isoform
of PLC exhibit motor discoordination and persistent multiple
CF innervation of adult cerebellar PCs (M.K., M.W., M.I.S.,
and D. Wu, unpublished data). These findings suggest that
elimination of multiple CF innervation during the third post-
natal week involves a defined signaling cascade in cerebellar
PCs that is composed of mGluR1, Gaq, PLC-b4, and PKCg.
All of these proteins may be tightly coupled in a multicom-
ponent signaling structure. There is precedence for such
complexes involving signaling proteins in other organisms (36,
37) and in the assembly of ion channels.
Both PKCg- and mGluR1-deficient mice are impaired in
motor coordination, and these mutant mice retain multiple CF
innervation into adulthood (19, 21, 28, 38). The innervation of
PCs by multiple CFs may disrupt the functional one-to-one
relationship between the inferior olivery neurons and PCs.
This may disturb a proper transfer of the ‘‘error’’ signals that
are necessary for motor learning in the cerebellar cortex (38).
We have found that Gaq mutant mice have persistent multiple
CF innervation and impaired motor coordination similar to
PKCg and mGluR1 mutant mice. This further supports the
hypothesis that CF mono-innervation is crucial for motor
coordination.
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